| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC2744 |
| Trial ID | NCT04991948 |
| Disease | Colorectal Cancer |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CYAD-101 |
| Co-treatment | FOLFOX |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer |
| Year | 2021 |
| Country | United States|Belgium |
| Company sponsor | Celyad Oncology SA |
| Other ID(s) | CYAD-101-002|KEYNOTE-B79 |
| Cohort 1 | |||||||||||
|
|||||||||||